These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Antibiotic therapy: a major cause of drug-induced jaundice in southwest England. Hussaini SH; O'Brien CS; Despott EJ; Dalton HR Eur J Gastroenterol Hepatol; 2007 Jan; 19(1):15-20. PubMed ID: 17206072 [TBL] [Abstract][Full Text] [Related]
29. Prolonged hepatic cholestasis after flucloxacillin therapy. Turner IB; Eckstein RP; Riley JW; Lunzer MR Med J Aust; 1989 Dec 4-18; 151(11-12):701-5. PubMed ID: 2593915 [TBL] [Abstract][Full Text] [Related]
30. Flucloxacillin hepatitis--an Australian epidemic. Desmond PV Aust N Z J Med; 1995 Jun; 25(3):195-6. PubMed ID: 7487684 [No Abstract] [Full Text] [Related]
31. Peri-operative renal morbidity secondary to gentamicin and flucloxacillin chemoprophylaxis for hip and knee arthroplasty. Ross AD; Boscainos PJ; Malhas A; Wigderowitz C Scott Med J; 2013 Nov; 58(4):209-12. PubMed ID: 24215038 [TBL] [Abstract][Full Text] [Related]
32. Updated study on risk of cholestatic liver disease and flucloxacillin. Li L; Jick H; Jick SS Br J Clin Pharmacol; 2009 Aug; 68(2):269-70. PubMed ID: 19694748 [No Abstract] [Full Text] [Related]
34. Flucloxacillin hepatitis: an Australian epidemic--comment. Blackmore TK; Wesselingh SL; Gordon DL Aust N Z J Med; 1995 Oct; 25(5):537. PubMed ID: 8588780 [No Abstract] [Full Text] [Related]
35. Cell Membrane Transporters Facilitate the Accumulation of Hepatocellular Flucloxacillin Protein Adducts: Implication in Flucloxacillin-Induced Liver Injury. Waddington JC; Ali SE; Penman SL; Whitaker P; Hamlett J; Chadwick A; Naisbitt DJ; Park BK; Meng X Chem Res Toxicol; 2020 Dec; 33(12):2939-2943. PubMed ID: 33169987 [TBL] [Abstract][Full Text] [Related]
36. Drug associated hepatic reactions in New Zealand: 21 years experience. Pillans PI N Z Med J; 1996 Aug; 109(1028):315-9. PubMed ID: 8816722 [TBL] [Abstract][Full Text] [Related]
37. Flucloxacillin-Induced Hepatotoxicity - Association with HLA-B*5701. Teixeira M; Macedo S; Batista T; Martins S; Correia A; Matos LC Rev Assoc Med Bras (1992); 2020; 66(1):12-17. PubMed ID: 32130375 [TBL] [Abstract][Full Text] [Related]
38. Renal impairment after high-dose flucloxacillin and single-dose gentamicin prophylaxis in patients undergoing elective hip and knee replacement. Challagundla SR; Knox D; Hawkins A; Hamilton D; W V Flynn R; Robertson S; Isles C Nephrol Dial Transplant; 2013 Mar; 28(3):612-9. PubMed ID: 23197677 [TBL] [Abstract][Full Text] [Related]
39. Risk factors for development of flucloxacillin associated jaundice. Fairley CK; McNeil JJ; Desmond P; Smallwood R; Young H; Forbes A; Purcell P; Boyd I BMJ; 1993 Jan; 306(6872):233-5. PubMed ID: 8443520 [TBL] [Abstract][Full Text] [Related]